神戸大学医学部附属病院は、神戸市中央区にある神戸大学医学部附属の大学病院。がん診療連携拠点病院、周産期母子医療センター設置病院、エイズ治療拠点病院、特定機能病院、兵庫県災害拠点病院でもある。略称は神大病院。 神戸大学医学部附属国際がん医療・研究センターは、分院にあたる。

During the past decade, Kobe University Hospital conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 28 clinical trials were completed, i.e. on average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 18 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kobe University Hospital" #1 sponsor was "Pfizer" with 9 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Actelion" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 65 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kobe University Hospital" #1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Kobe University Hospital" are "Alzheimer Disease" (5 trials), "Psoriasis" (4 trials), "Duchenne Muscular Dystrophy" (3 trials), "Alport Syndrome" (2 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Kobe University Hospital" in a lesser frequency.

Most popular intervention types in "Kobe University Hospital" are "Drug" (83 trials), "Other" (9 trials), "Device" (7 trials), "Biological" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Atezolizumab" (3 trials), "BMS-986165" (3 trials), "Cisplatin" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kobe University Hospital" are 92 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kobe University Hospital". undefined are not yet recruiting, 20 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Kobe University Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Kobe University Hospital, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".